Established in April 2008, Xiamen Biotime Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of point-of-care testing (POCT) in vitro diagnostic devices and reagents. The company is committed to providing innovative, high-quality products to improve healthcare solutions. Their product range includes immunofluorescence reagents, immunoassay analyzers, and various rapid test kits for diseases like COVID-19, malaria, and RSV.